249 related articles for article (PubMed ID: 9815528)
1. [Oral contraceptives and endometrial and ovarian carcinomas].
Medl M
Gynakol Geburtshilfliche Rundsch; 1998; 38(2):105-8. PubMed ID: 9815528
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
Gwinn ML
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
[TBL] [Abstract][Full Text] [Related]
4. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
5. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
6. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
7. The pill and cancer: a review of the literature. A case of swings and roundabouts?
Knowlden HA
J Adv Nurs; 1990 Sep; 15(9):1016-20. PubMed ID: 2229699
[TBL] [Abstract][Full Text] [Related]
8. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
9. Neoplastic effects of oral contraceptives.
Grimes DA
Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
[TBL] [Abstract][Full Text] [Related]
10. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
11. The contraceptive pill and breast cancer in young women.
Drife JO
BMJ; 1989 May; 298(6683):1269-70. PubMed ID: 2500194
[TBL] [Abstract][Full Text] [Related]
12. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and neoplasia.
Stubblefield PG
J Reprod Med; 1984 Jul; 29(7 Suppl):524-9. PubMed ID: 6481705
[TBL] [Abstract][Full Text] [Related]
14. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and breast cancer.
Thomas DB
J Natl Cancer Inst; 1993 Mar; 85(5):359-64. PubMed ID: 8433389
[TBL] [Abstract][Full Text] [Related]
16. Hormonal contraception.
Baird DT; Glasier AF
N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
[TBL] [Abstract][Full Text] [Related]
17. Ovarian and endometrial function during hormonal contraception.
ESHRE Capri Workshop Group
Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842
[TBL] [Abstract][Full Text] [Related]
18. OCs and genital tract malignancies.
Herbst AL
Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
[TBL] [Abstract][Full Text] [Related]
19. Expanded role for OCs. Question and answer.
Mishell Dr
Dialogues Contracept; 1994; 4(3):8. PubMed ID: 12345576
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of endometrial cancer in young women.
Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
